Stratifai
Berlin, DE · Founded 2023 · 3 known investors
StratifAI develops Polaris, an AI platform that links histology, RNA-seq, and patient outcomes to analyze spatial biology for cancer research. Its first diagnostic, Polaris Breast, assesses metastatic risk in early breast cancer from digitized histology slides and is currently for research use only while pursuing regulatory approval in the EU and US.
Founders & leadership
Stratifai was founded in 2023 by Daniel Truhn, Firas Khader, Jakob Nikolas Kather, and Omar El Nahhas.
DT
Daniel TruhninCo-Founder & Chief Medical Officer
FK
JN
OE
Omar El Nahhasin𝕏Co-Founder & CEOComputational-pathology researcher (TU Dresden / Kather lab); CEO of StratifAI.
Investors · 3
Frequently asked questions
- What does Stratifai do?
- StratifAI develops Polaris, an AI platform that links histology, RNA-seq, and patient outcomes to analyze spatial biology for cancer research. Its first diagnostic, Polaris Breast, assesses metastatic risk in early breast cancer from digitized histology slides and is currently for research use only while pursuing regulatory approval in the EU and US.
- Who founded Stratifai?
- Stratifai was founded by Daniel Truhn, Firas Khader, Jakob Nikolas Kather, Omar El Nahhas in 2023.
- Who are Stratifai's investors?
- Stratifai's investors include Debiopharm Innovation Fund, PICUS CAPITAL, Alven.
- Where is Stratifai headquartered?
- Stratifai is headquartered in Berlin, DE.